Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …
communicable diseases, including heart disease and cancer, morbidity and mortality due to …
Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation
Background Dupilumab, a fully human monoclonal antibody that blocks the shared receptor
component for interleukin-4 and interleukin-13, key and central drivers of type 2 …
component for interleukin-4 and interleukin-13, key and central drivers of type 2 …
Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary |
European Respiratory Society Skip to main content Top Menu ERS website Respiratory …
European Respiratory Society Skip to main content Top Menu ERS website Respiratory …
Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision
Attempts to define concepts and things date back to the time of Aristotle, around 2,400 years
ago, when he proposed that a definition should state the essential nature or being of …
ago, when he proposed that a definition should state the essential nature or being of …
Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD
Background Triple fixed-dose regimens of an inhaled glucocorticoid, a long-acting
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
muscarinic antagonist (LAMA), and a long-acting β2-agonist (LABA) for chronic obstructive …
Chronic obstructive pulmonary disease (Japanese Version)
WW Labaki, SR Rosenberg - Annals of internal medicine, 2020 - acpjournals.org
Disclosures: Dr. Labaki, ACP Contributing Author, reports nonfinancial support from
Pulmonx and personal fees from Konica Minolta outside the submitted work. Dr. Rosenberg …
Pulmonx and personal fees from Konica Minolta outside the submitted work. Dr. Rosenberg …
COPD guidelines: a review of the 2018 GOLD report
S Mirza, RD Clay, MA Koslow, PD Scanlon - Mayo Clinic Proceedings, 2018 - Elsevier
Abstract Global Strategy for the Diagnosis, Management, and Prevention of COPD 2018 is a
consensus report published periodically since 2001 by an international panel of health …
consensus report published periodically since 2001 by an international panel of health …
Update on clinical aspects of chronic obstructive pulmonary disease
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
[Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …
then have undergone a series of updates incorporating new evidence on the diagnosis and …